hCG Activatornone

Other Combinations

Brand: Biomedx Research

Tablet or PillOther CombinationsOff Market
Click to view full label

Net Contents

120 Tablet(s)

Serving Size

1 Tablet(s)

Servings Per Container

120

Supplement Form

Tablet or Pill

Bar Code (UPC/SKU)

6 89076 03181 3

Product Version

F15

Label Analysis

Objective insights generated automatically from the official DSLD label — a quick, factual read of how this product is formulated and disclosed.

2Active Ingredients

2 distinct active ingredients are disclosed in Supplement Facts.

100%Amount Transparency

Label includes a proprietary blend, so some individual amounts are not itemized.

1% Daily Value Coverage

1 ingredients report an established %DV per serving.

This analysis is generated algorithmically from label data for educational reference only. It is not a product endorsement, ranking, or medical advice.

Supplement Facts

Serving Size: 1 Tablet(s) · 3 per day

IngredientAmount Per Serving% Daily Value
Niacin16 mg80%
Proprietary Blend (Combination)149 mg
L-Ornithine Monohydrochloride
L-Carnitine HCl
L-Glutamic Acid(L-Glutamic Acid Hydrochloride)
L-Beta-Alanine
Maca root extract
Pygeum bark extract
Astragalus root extract
Rhodiola rosea root extract(Stevia)

Not Present

Other Ingredients

SorbitolMicrocrystalline CelluloseNatural flavorStearic AcidCitric AcidMagnesium StearateSiliconCroscarmellose Sodium

Target Groups

Adult (18 - 50 Years)

Label Claims

All OtherStructure/Function

Directions & Suggested Use

Suggested/Recommended/Usage/Directions

Suggested Use: Take one tablet three times daily during maintenance phase. Allow tablet to dissolve under the tongue.

Warnings & Precautions

Precautions re: Pregnant or Nursing or Prescription Medications

Warning: do not use when pregnant or nursing.

Precautions re: Children

Not for use by persons under 18 years of age.

Precautions re: All Other

Do not use without consulting your health care professional, if you have any existing medical condition. Do not exceed recommended dosage.

Precautions re: Children

Keep out of reach of children.

FDA Statements

FDA Statement of Identity

Dietary Supplement

FDA Disclaimer Statement

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.

Other Label Statements

Seals/Symbols

Made in USA

General: Product/Version Code

F15

Manufacturer & Distributor

Distributor

Biomedx Research

San Francisco, CA, 94133

(855)962-2555

Where to Buy Locally

Enter your city or ZIP code to find supplement & health stores in your area that may carry this product.

Showing representative supplement & health retailers — search above for stores in your area.

Research & Studies

  • Treatment of human oocytes with extracellular vesicles from follicular fluid during rescue in vitro maturation enhances maturation rates and modulates oocyte …

    S Makieva, MD Saenz-de-Juano… - Human …, 2026 - academic.oup.com

    20266 citations
  • Treatment of human oocytes with extracellular vesicles from follicular fluid during 2 rescue in vitro maturation enhances maturation rates and modulates oocyte …

    MX Bernal-Ulloa, AG Velasco, N Cervantes, M Sachs… - 2026 - researchgate.net

    … research fellowship and a FAN research grant (Fonds zur Förderung des akademischen … the addition of a GnRH-agonist accompanied by about 1600 IE hCG within the GnRH- …

    2026
  • Simplified vitrification-warming protocol in donor oocytes: artificial intelligence-based oocyte competence and clinical outcomes

    L Murria, L Conversa, J Gil… - Reproductive …, 2026 - Elsevier

    … , positive β-hCG rate, clinical pregnancy rate and ongoing pregnancy rate, were analyzed as exploratory outcomes. Positive β-hCG was defined as a serum β-hCG concentration ≥25 …

    2026
  • Pregnancy AI: Development and Internal Validation of an Artificial Intelligence Tool to Predict Live Births in ICSI and IVF Cycles Using Clinical Features and …

    J Minano Masip, P Borduas, IJ Kadoch, S Phillips… - Medicina, 2026 - mdpi.com

    2026
  • Vitrification-warming delays preimplantation development and impairs mitochondrial function and cytoplasmic lattices integrity in mouse embryos

    MT Barroso, JAR Muñoz, V Sjöström, K Dindini, J Zhao… - iScience, 2026 - cell.com

    … development and offspring health. Recent population-based registry studies have raised … All data associated with this study are present in the paper or supplemental information. …

    20261 citations
  • Comparison of one-step and conventional warming in sibling donor oocytes: a proof-of-concept study

    A Cobo, A Coello, L Murria, Y Garijo… - Reproductive …, 2026 - Elsevier

    … Few studies have evaluated the efficiency of using shorter protocols on oocytes. Excellent survival rates, integrity of the … To date, seven healthy infants have been born in each group. …

    20262 citations

Data sourced from the U.S. National Institutes of Health, Office of Dietary Supplements Dietary Supplement Label Database (DSLD) · Label entered 2016-11-21. DSLD Label ID: 66518. This information is provided for educational reference only and is not medical advice. Always follow the product label and consult a doctor or pharmacist before use.